心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

美国心脏协会《药物依从性和血压控制》科学声明解读

2022-04-15 中国医学科学院北京协和医学院北京协和医院药剂科 临床药物治疗杂志

血压控制药物依从性

2020年美国心脏协会（AHA）发布《药物依从性：重要性、问题和策略》政策声明，讨论了药物依从性对心血管疾病管理的重要性。随着越来越多的证据出现，2021年10月7日AHA发布《药物依从性和血压控制》

中文标题：

美国心脏协会《药物依从性和血压控制》科学声明解读

发布机构：

中国医学科学院北京协和医学院北京协和医院药剂科

发布日期：

2022-04-15

简要介绍：

2020年美国心脏协会（AHA）发布《药物依从性：重要性、问题和策略》政策声明，讨论了药物依从性对心血管疾病管理的重要性。随着越来越多的证据出现，2021年10月7日AHA发布《药物依从性和血压控制》科学声明，基于当前证据全面阐述药物依从性对血压控制的影响。本文重点解读药物依从性的评估方法、影响因素和干预措施等策略，提供针对性和操作性的指导。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=美国心脏协会《药物依从性和血压控制》科学声明解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=49ef81c0025a1055, title=美国心脏协会《药物依从性和血压控制》科学声明解读, enTitle=, guiderFrom=临床药物治疗杂志, authorId=0, author=, summary=2020年美国心脏协会（AHA）发布《药物依从性：重要性、问题和策略》政策声明，讨论了药物依从性对心血管疾病管理的重要性。随着越来越多的证据出现，2021年10月7日AHA发布《药物依从性和血压控制》, cover=https://img.medsci.cn/20220723/1658561318314_1608702.jpg, journalId=0, articlesId=null, associationId=2996, associationName=中国医学科学院北京协和医学院北京协和医院药剂科, associationIntro=中国医学科学院北京协和医学院北京协和医院药剂科, copyright=0, guiderPublishedTime=Fri Apr 15 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">2020年美国心脏协会（AHA）发布《药物依从性：重要性、问题和策略》政策声明，讨论了药物依从性对心血管疾病管理的重要性。随着越来越多的证据出现，2021年10月7日AHA发布《药物依从性和血压控制》科学声明，基于当前证据全面阐述药物依从性对血压控制的影响。本文重点解读药物依从性的评估方法、影响因素和干预措施等策略，提供针对性和操作性的指导。&nbsp;</span></p>, tagList=[TagDto(tagId=7897, tagName=血压控制), TagDto(tagId=48082, tagName=药物依从性)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1696, appHits=55, showAppHits=0, pcHits=204, showPcHits=1641, likes=1, shares=8, comments=4, approvalStatus=1, publishedTime=Mon Jul 25 20:42:00 CST 2022, publishedTimeString=2022-04-15, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Sat Jul 23 15:28:12 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Thu Jan 04 21:17:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=美国心脏协会《药物依从性和血压控制》科学声明解读.pdf)])
美国心脏协会《药物依从性和血压控制》科学声明解读.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1235219, encodeId=e9b3123521989, content=能够读到原文就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/1ac509b02e474a62b04821218d545591/41999e8f8740491a9831ef637a726745.jpg, createdBy=6c8a5450541, createdName=ms8000000374682656, createdTime=Thu Jul 28 08:27:17 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234761, encodeId=0e5f1234e615b, content=认真学习～～, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Tue Jul 26 07:17:12 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234704, encodeId=c3741234e0428, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b2d1930182, createdName=小路非, createdTime=Mon Jul 25 21:01:59 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-07-28 ms8000000374682656

    能够读到原文就好了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1235219, encodeId=e9b3123521989, content=能够读到原文就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/1ac509b02e474a62b04821218d545591/41999e8f8740491a9831ef637a726745.jpg, createdBy=6c8a5450541, createdName=ms8000000374682656, createdTime=Thu Jul 28 08:27:17 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234761, encodeId=0e5f1234e615b, content=认真学习～～, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Tue Jul 26 07:17:12 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234704, encodeId=c3741234e0428, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b2d1930182, createdName=小路非, createdTime=Mon Jul 25 21:01:59 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-07-26 xulv123

    认真学习～～

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1235219, encodeId=e9b3123521989, content=能够读到原文就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/1ac509b02e474a62b04821218d545591/41999e8f8740491a9831ef637a726745.jpg, createdBy=6c8a5450541, createdName=ms8000000374682656, createdTime=Thu Jul 28 08:27:17 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234761, encodeId=0e5f1234e615b, content=认真学习～～, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Tue Jul 26 07:17:12 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234704, encodeId=c3741234e0428, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b2d1930182, createdName=小路非, createdTime=Mon Jul 25 21:01:59 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-07-25 小路非

    学习了

    0

相关指南

2021 TSS指南：预防缺血性卒中的血压控制

台湾脑中风学会 · 2022-06-01